Actively Recruiting
CPRIT: Patient Adherence to Lung Cancer Screening
Led by M.D. Anderson Cancer Center · Updated on 2025-04-02
340
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand the challenges participants face when scheduling and completing lung cancer screening. It evaluates adherence rates to lung cancer screening guidelines among patients at the UTMB and UT Tyler programs. The study also explores participants' experiences and barriers to screening, along with insights from program directors and staff to improve screening rates. Participants who join this observational study will take part in interviews about their background, lung cancer history, and experiences with scheduling lung cancer screening. Researchers will use advanced machine learning methods to create prediction models that identify factors influencing screening adherence, using data from multiple sources. Participants will be interviewed about their lung cancer screening experience and any obstacles they faced. The study monitors safety and adverse events over about one year. Researchers will gather information through surveys and interviews with patients and staff to better understand screening challenges and improve future lung cancer screening programs.
CONDITIONS
Brief Title
CPRIT: Patient Adherence to Lung Cancer Screening
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Current smoker or quit within the past 15 years
- A 20 or more pack-year smoking history
- Healthy enough for treatment
- Aged between 50 and 80 years
You will not qualify if you...
- Not applicable as the study focuses on patients with an order for screening at UTMB or UT Tyler
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants take part in interviews about their background, lung cancer diagnosis, screening history, scheduling experience, and barriers to completing screening.
1 to 2 visits depending on participant availability
Duration - Up to 1 year
Participants are observed for safety and adverse events throughout the study period.
Periodic contact or assessment as needed
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
R
Robert Volk, PHD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here